Charles Chiang, MD | |
5757 Harper Dr Ne, Albuquerque, NM 87109-3566 | |
(505) 888-5757 | |
(505) 865-0160 |
Full Name | Charles Chiang |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 24 Years |
Location | 5757 Harper Dr Ne, Albuquerque, New Mexico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154321156 | NPI | - | NPPES |
P00201687 | Other | NM | MEDICARE ID |
NM009U33 | Other | NM | BC BS OF NM |
04104722 | Medicaid | NM | |
926389 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | MD2004-0711 (New Mexico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lovelace Medical Center | Albuquerque, NM | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Eye Associates Of New Mexico Ltd | 4486643616 | 58 |
News Archive
Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Watson Pharmaceuticals, Inc. today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.
The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.
Researchers at Kessler Foundation have studied the measurement tools used in multiple sclerosis for their effectiveness in predicting employment status. They compared the Expanded Disability Status Scale (EDSS), the Multiple Sclerosis Functional Composite (MSFC), the Paced Auditory Serial Addition Task (PASAT), and the Symbol Digit Modalities Test (SDMT), and found the SDMT effective in differentiating employed from unemployed individuals.
› Verified 1 days ago
Entity Name | Eye Associates Of New Mexico Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104868520 PECOS PAC ID: 4486643616 Enrollment ID: O20040511001422 |
News Archive
Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Watson Pharmaceuticals, Inc. today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.
The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.
Researchers at Kessler Foundation have studied the measurement tools used in multiple sclerosis for their effectiveness in predicting employment status. They compared the Expanded Disability Status Scale (EDSS), the Multiple Sclerosis Functional Composite (MSFC), the Paced Auditory Serial Addition Task (PASAT), and the Symbol Digit Modalities Test (SDMT), and found the SDMT effective in differentiating employed from unemployed individuals.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Charles Chiang, MD 8801 Horizon Blvd Ne, Suite 360, Albuquerque, NM 87113-1533 Ph: (505) 246-2622 | Charles Chiang, MD 5757 Harper Dr Ne, Albuquerque, NM 87109-3566 Ph: (505) 888-5757 |
News Archive
Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.
Researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Roswell Park Cancer Institute have received an $8 million grant from the National Cancer Institute to study the effects of photodynamic light therapy (PDT) in patients with malignant pleural mesothelioma, a rare, aggressive and deadly cancer that most often manifests itself in the lining of the lungs and is caused almost exclusively by exposure to asbestos.
Watson Pharmaceuticals, Inc. today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.
The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.
Researchers at Kessler Foundation have studied the measurement tools used in multiple sclerosis for their effectiveness in predicting employment status. They compared the Expanded Disability Status Scale (EDSS), the Multiple Sclerosis Functional Composite (MSFC), the Paced Auditory Serial Addition Task (PASAT), and the Symbol Digit Modalities Test (SDMT), and found the SDMT effective in differentiating employed from unemployed individuals.
› Verified 1 days ago
Rebecca Suzanne Leenheer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 303 Mulberry St Ne, Albuquerque, NM 87106 Phone: 505-243-9739 Fax: 505-842-0650 | |
Ana G Huaman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3901 Georgia St Ne Ste G-2, Albuquerque, NM 87110 Phone: 505-266-8200 Fax: 505-256-7565 | |
John E Graham, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5400 Gibson Blvd Se, Albuquerque, NM 87108 Phone: 505-262-3937 Fax: 505-262-7147 | |
Dr. Michael Scott Seligson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4343 Pan American Fwy Ne, Ste. 224, Albuquerque, NM 87107 Phone: 505-344-5400 Fax: 505-344-5404 | |
Dr. Ian Abban Thompson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4411 The 25 Way Ne Ste 325, Albuquerque, NM 87109 Phone: 505-823-4411 Fax: 505-343-6085 | |
Robert K Rothberg, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5150 Journal Center Blvd Ne, Albuquerque, NM 87109 Phone: 505-262-3937 Fax: 505-262-3366 |